Demonstrates improved receptor binding and therapeutic benefits of engineered botulinum neurotoxin A, suggesting safer clinical use.
Cryo-EM Structure Guided Engineering of Botulinum Neurotoxin A This futuristic cover depicts a golden magic hand for highlighting the engineering of botulinum neurotoxin type A. It illustrates that the structure-guided design optimizes wild-type toxin to enhance its receptor binding affinity, improve its therapeutic benefits, lower its diffusion from the local injection site, and increase safety for future clinical use. More details can be found in the Research Article by Dongsheng Wang, Dejuan Zhi, Dongsheng Lei and co-workers. (DOI: 10.1002/advs.202516713).
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: